Clinical trial
Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) - Alpha-1 Protocol
NCT01832220 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) - Alpha-1 Protocol
- Lead sponsor
- University of Pittsburgh
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2013
- Completion date
- September 30, 2015
- Enrollment
- 140 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
aatd, alpha 1 antitrypsin deficiency